🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the investigators assessed the effect of Cetuximab in combin...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2006-09
Trial ID
NCT01564810
Treatments Being Tested
To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Status
Unknown
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-08-01
Trial ID
NCT05797883
Treatments Being Tested
A first in human study to evaluate the safety and preliminary antitumor act...
Status
Recruiting
Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Start Date
2025-03-31
Trial ID
NCT06917079
The purpose of this study is to evaluate efficacy and safety of mFOLFOX6+be...
Status
Completed
Location
EPS Corporation
Start Date
2013-05
Trial ID
NCT01836653
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
The purpose of this trial is to evaluate how well petosemtamab in combinati...
Status
Recruiting
Location
Vista Oncology
Start Date
2026-08-11
Trial ID
NCT07702032
Treatments Being Tested
This trial will evaluate the combination of modified infusional 5-fluoroura...
Status
Completed
Location
Oncology Hematology Associates of SW Indiana
Start Date
2005-07
Trial ID
NCT00193219
Treatments Being Tested
The main objective is to evaluate progression-free survival (PFS) at 4 mont...
Status
Completed
Location
Centre rené Gauducheau
Start Date
2010-12
Trial ID
NCT01442649
Treatments Being Tested
This is a prospective randomized controlled Phase Ⅱ/Ⅲ Clinical study to eva...
Status
Not Yet Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
Start Date
2025-06-01
Trial ID
NCT06959693
Treatments Being Tested
Nordic randomized phase II trial which evaluates whether biweekly cetuximab...
Status
Completed
Location
Aalborg University Hospital
Start Date
2012-05
Trial ID
NCT01867697
Treatments Being Tested